LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
LFCR on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
37,435,082
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24,334,794
Holdings value
$179,104,808
% of all portfolios
0.003%
Number of holders
98
Number of buys
46
Number of sells
-35
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Greenhaven Road Investment Management, L.P. 9.8% +25% $22,998,689 +$7,944,848 3,616,146 +52.8% Greenhaven Road Investment Management, L.P. 31 Dec 2024
22NW Fund, LP 7.49% -32.8% $20,768,278 -$9,716,865 2,975,398 -31.9% 22NW Fund, LP 27 May 2025
BlackRock, Inc. 4.9% -2% $13,501,322 -$251,608 1,834,319 -1.8% BlackRock, Inc. 30 Sep 2025
David Capital Partners, LLC 4.87% $11,467,080 1,803,000 David Capital Partners, LLC 31 Dec 2024

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 24,334,794 $179,104,808 -$442,653 $7.36 98
2025 Q2 24,384,958 $198,008,217 +$13,339,387 $8.12 84
2025 Q1 22,755,067 $160,201,265 -$2,326,304 $7.04 85
2024 Q4 23,042,098 $171,205,266 +$31,378,307 $7.43 74
2024 Q3 18,933,619 $93,344,132 +$959,877 $4.93 80
2024 Q2 18,597,383 $95,407,619 -$6,051,109 $5.13 73
2024 Q1 21,527,122 $114,309,004 +$1,281,084 $5.31 75
2023 Q4 21,214,493 $131,315,483 +$7,746,225 $6.19 77
2023 Q3 17,649,982 $132,309,917 -$4,239,641 $7.54 67
2023 Q2 17,960,139 $173,672,855 -$23,585,436 $9.67 73
2023 Q1 21,626,729 $81,665,566 -$19,155,973 $3.78 79
2022 Q4 24,699,229 $160,060,929 -$420,882 $6.48 92
2022 Q3 24,756,452 $220,096,095 -$5,076,219 $8.89 84
2022 Q2 25,281,897 $252,055,903 -$4,813,620 $9.97 86
2022 Q1 23,496,502 $272,006,071 -$4,453,715 $11.58 94
2021 Q4 25,875,011 $287,157,179 +$3,096,368 $11.1 95
2021 Q3 25,537,059 $235,449,630 +$11,336,792 $9.22 91
2021 Q2 25,595,693 $287,942,521 -$5,835,307 $11.25 95
2021 Q1 25,969,624 $275,201,016 -$6,203,031 $10.6 92
2020 Q4 26,546,714 $288,027,507 -$1,865,390 $10.85 95
2020 Q3 27,293,895 $265,303,644 +$8,398,552 $9.72 95
2020 Q2 26,759,176 $213,024,082 -$2,393,394 $7.96 91
2020 Q1 27,069,384 $235,223,542 -$2,453,651 $8.69 87
2019 Q4 27,094,595 $306,434,334 +$278,864 $11.31 92
2019 Q3 26,498,684 $287,625,125 -$10,583,915 $10.87 102
2019 Q2 27,497,586 $257,653,097 +$10,011,387 $9.37 98
2019 Q1 26,312,887 $323,120,159 +$5,328,462 $12.28 90
2018 Q4 25,883,944 $306,456,062 -$563,058 $11.84 88
2018 Q3 25,680,348 $367,065,569 -$2,817,222 $14.4 89
2018 Q2 25,073,308 $373,595,030 -$6,657,193 $14.9 89
2018 Q1 26,316,857 $343,465,751 +$5,904,468 $13.05 88
2017 Q4 25,838,571 $325,371,521 -$304,837 $12.6 90
2017 Q3 25,804,476 $334,160,959 +$6,036,656 $12.95 92
2017 Q2 25,319,960 $375,969,466 +$3,371,779 $14.85 92
2017 Q1 25,099,442 $301,208,568 +$26,792,518 $12 83
2016 Q4 24,664,192 $340,389,514 -$4,315,145 $13.8 91
2016 Q3 25,035,867 $335,724,442 -$8,276,505 $13.41 90
2016 Q2 25,716,341 $276,698,218 +$13,954,300 $10.76 92
2016 Q1 25,062,413 $263,156,774 +$7,503,955 $10.5 91
2015 Q4 24,362,954 $288,513,037 +$6,283,639 $11.83 106
2015 Q3 23,756,250 $277,238,057 -$6,250,112 $11.67 108
2015 Q2 24,236,757 $349,729,789 -$429,367 $14.43 107
2015 Q1 24,035,177 $335,230,454 -$392,081 $13.95 97
2014 Q4 24,080,381 $332,562,030 -$1,269,800 $13.81 105
2014 Q3 24,257,148 $294,986,600 +$2,810,099 $12.25 105
2014 Q2 23,981,587 $299,475,311 +$4,217,262 $12.49 99
2014 Q1 23,665,087 $264,250,906 -$9,506,174 $11.16 96